Mannatech (NASDAQ:MTEX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a note issued to investors on Thursday. The firm set a “buy” rating on the stock.

Mannatech Trading Up 2.1 %

NASDAQ MTEX opened at $7.88 on Thursday. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54. Mannatech has a twelve month low of $6.75 and a twelve month high of $10.51. The firm has a market capitalization of $14.85 million, a PE ratio of -8.85 and a beta of 1.17. The stock’s 50 day moving average is $7.48 and its 200 day moving average is $7.60.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The firm had revenue of $27.74 million for the quarter.

Insider Activity at Mannatech

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the sale, the director now directly owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 41.50% of the stock is currently owned by corporate insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.